ESLHO logo

Program of the 10th ESLHO Symposium

Thursday November 11, 2021

08:00 – 13:00
Registration for the symposium
08:30 – 12:00
IVDR workshop
12:00 – 13:00
Lunch
13:00 – 13:05
Welcome
13:05 – 15:00
SESSION 1: Advanced immune monitoring
  • Technical developments for advanced flow cytometric immune monitoring
    Cristina Teodosio, Leiden, NL
  • SARS-CoV-2 specific CD4+ T-cells and TCR repertoire analysis in unexposed individuals and patients with COVID-19
    Petra Bacher, Kiel, DE
  • Abstract-based presentations
15:00 – 15:30
Coffee break
15:30 – 17:00
SESSION 2: Targeting the immune system
  • Current cancer immunotherapies and their targets
    Martino Introna, Bergamo, IT
  • The senescence-associated innate immune sensors in early-stage lung cancer treatment and diagnostics
    Juan Carlos Acosta, Edinburgh, UK
  • Abstract-based presentations
17:00 – 18:30
SESSION 3: Escape from immunotherapy
  • Antibody engineering to improve leukemia immunotherapy
    Matthias Peipp, Kiel, DE
  • Leukemia escape mechanisms after antibody and other targeted immune therapies
    Luca Vago, Milano, IT
  • Abstract-based presentations

Friday November 12, 2021

08:00 - 10:00
SESSION 4: CAR T-cell therapy
  • How to choose between antibody-based immunotherapy and CAR-T cells? ALL as a paradigm
    Tomasz Szczepański, Zabrze, PL
  • CAR T-cell therapy in acute lymphoblastic leukemia: monitoring of T-cell expansion and exhaustion
    Dario Campana, Singapore, SG
  • Monitoring of CAR T-cell therapy in multiple myeloma
    Alberto Orfao, Salamanca, ES
  • Abstract-based presentations
10:00 - 10:30
Coffee break
10:30 – 11:45
SESSION 5: MRD and immune monitoring
  • Advances in molecular MRD monitoring
    Jan Trka, Prague, CZ
  • MRD monitoring vs. monitoring of CAR-T cell persistence in ALL
    Giuseppe Gaipa, Monza, IT
  • Abstract-based presentations
11:45 – 12:45
SESSION 6: Round table discussion: Companion diagnostics and the role of European Networks
Moderators: Jacques J.M. van Dongen and Monika Brüggemann
  • Introduction: Companion Diagnostics: MRD and immune monitoring for guiding therapy
    Jacques J.M. van Dongen, Leiden, NL
12:45 – 13:00
Closing remarks
13:00 – 14:00
Lunch